Epigenetic regulatory pathways in human leukaemia
Ontology highlight
ABSTRACT: 3 acute myeloid leukaemic cell lines and 1 control non-small cell lung cancer cell line were treated for 24h with 2 different doses of the KAT2A inhibitor 3-butyrolactone or DMSO vehicle.
INSTRUMENT(S): Illumina HiSeq 2000
ORGANISM(S): Homo sapiens
SUBMITTER:
PROVIDER: E-ERAD-213 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA